Tufts launches website/HUB for pharma partnerships

Tufts University's Institute for Biomedical Partnerships has launched its new website/HUB that focuses on its global pharmaceutical partnering initiative. It includes more than 50 experts from six university research centers and focuses on five thematic areas of drug discovery and development expertise. "Our objective is to form innovative drug discovery and development alliances between Tufts and the pharma industry based on existing assets of strategic interest, while generating revenue streams to benefit the university and industry alike," Lawrence Botticelli, the institute's founder, said in a news release. The site provides immediate access to nearly 60 research activities driven by more than 50 participating faculty members with navigable information in more than 300 categories. Tufts release | Website

Suggested Articles

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.